scholarly journals Health technology assessment and its role in the future development of the Indian healthcare sector

2012 ◽  
Vol 3 (2) ◽  
pp. 66 ◽  
Author(s):  
Bastian Hass ◽  
Jayne Pooley ◽  
Viraj Suvarna ◽  
Martin Feuring ◽  
AdrianE Harrington
Keyword(s):  
Health Technology Assessment ◽  
Future Development ◽  
Technology Assessment ◽  
Health Technology ◽  
Healthcare Sector ◽  
The Future

Survey on the involvement of consumers in health technology assessment programs

2006 ◽  
Vol 22 (4) ◽  
pp. 497-499 ◽  
Author(s):  
David Hailey ◽  
Margareta Nordwall
Keyword(s):  
Health Technology Assessment ◽  
Technology Assessment ◽  
Health Technology ◽  
International Network ◽  
The Future

Objectives: The aim of this study was to obtain information from members of the International Network of Agencies for Health Technology Assessment (INAHTA) on their involvement of consumers (patients, carers, and related organizations) in their programs.Methods: A questionnaire for a survey was developed and sent to member agencies in October 2005.Results: Of the thirty-seven agencies that provided responses, 57 percent involve consumers in some aspects of their HTA programs and 83 percent intend to involve consumers in the future. Summaries of HTA reports that are intended to be easily understood by consumers are prepared by 49 percent of the agencies, and 36 percent involve consumers in dissemination of HTA material.Conclusions: Most INAHTA members involve consumers in some aspects of their programs, although not always routinely. Involvement seems likely to increase in the future.

scholarly journals The Future of Precision Medicine: Potential Impacts for Health Technology Assessment

2018 ◽  
Vol 36 (12) ◽  
pp. 1439-1451 ◽  
Author(s):  
James Love-Koh ◽  
Alison Peel ◽  
Juan Carlos Rejon-Parrilla ◽  
Kate Ennis ◽  
Rosemary Lovett ◽  
...  
Keyword(s):  
Health Technology Assessment ◽  
Precision Medicine ◽  
Technology Assessment ◽  
Health Technology ◽  
The Future

The future of best investing in vaccines: The Health Technology Assessment approach

Vaccine ◽  
2008 ◽  
Vol 26 (13) ◽  
pp. 1609-1610 ◽  
Author(s):  
Giuseppe La Torre ◽  
Chiara de Waure ◽  
Giacomina Chiaradia ◽  
Alice Mannocci ◽  
Maria Lucia Specchia ◽  
...  
Keyword(s):  
Health Technology Assessment ◽  
Technology Assessment ◽  
Health Technology ◽  
The Future ◽  
Assessment Approach

Health Technology Assessment in Health Economics

2011 ◽  
pp. 69-86
Author(s):  
Steven Simoens
Keyword(s):  
Health Economics ◽  
Health Technology Assessment ◽  
Technology Assessment ◽  
Health Expenditure ◽  
Health Technology ◽  
Decision Makers ◽  
Added Value ◽  
Healthcare Sector ◽  
Scarce Resources ◽  
Health Technologies

This chapter introduces health technology assessment and health economics as tools for decision makers to allocate scarce resources in the healthcare sector. It argues that information about the safety, efficacy and effectiveness, organizational implications, social and ethical consequences, legal considerations, and health economic aspects of the application of a health technology needs to be taken into account with a view to informing decisions about the registration and reimbursement of a health technology. Also, the author hopes that understanding the methodology and use of health technology assessment and health economics will persuade the reader of the added value of such studies and promote the application of health technologies that support further health improvements, whilst containing health expenditure.

scholarly journals Correction to: The Future of Precision Medicine: Potential Impacts for Health Technology Assessment

2018 ◽  
Vol 37 (1) ◽  
pp. 117-117
Author(s):  
James Love-Koh ◽  
Alison Peel ◽  
Juan Carlos Rejon-Parrilla ◽  
Kate Ennis ◽  
Rosemary Lovett ◽  
...  
Keyword(s):  
Health Technology Assessment ◽  
Precision Medicine ◽  
Technology Assessment ◽  
Health Technology ◽  
The Future

A SHORT HISTORY OF INAHTA

1999 ◽  
Vol 15 (1) ◽  
pp. 236-242 ◽  
Author(s):  
David Hailey ◽  
Devidas Menon
Keyword(s):  
Health Technology Assessment ◽  
Technology Assessment ◽  
Health Technology ◽  
Short History ◽  
International Network ◽  
Exchange Of Information ◽  
The Future ◽  
Joint Health ◽  
History Of

The need for better communication and collaboration between health technology assessment agencies led to the formation of an International Network of Agencies for Health Technology Assessment (INAHTA). The network now comprises 27 agencies and has been successful in improving exchange of information and in undertaking joint health technology assessment projects. Issues for the future include possible changes to criteria for membership and identification of resources for more extensive programs.

scholarly journals A health technology assessment between two pharmacological therapies through Six Sigma: the case study of bone cancer

2020 ◽  
Vol 32 (6) ◽  
pp. 1507-1524 ◽  
Author(s):  
Carlo Ricciardi ◽  
Alfonso Sorrentino ◽  
Giovanni Improta ◽  
Vincenzo Abbate ◽  
Imma Latessa ◽  
...  
Keyword(s):  
Health Technology Assessment ◽  
Technology Assessment ◽  
Six Sigma ◽  
Maxillofacial Surgery ◽  
Health Technology ◽  
University Hospital ◽  
Healthcare Sector ◽  
Main Theme ◽  
Content Type ◽  
Hospitalization Costs

PurposeHead and neck cancers are multi-factorial diseases that can affect many sides of people's life and are due to a lot of risk factors. According to their characteristics, the treatment can be surgical, use of radiation or chemotherapy. The use of a surgical treatment can lead to surgical infections that are a main theme in medicine. At the University hospital of Naples “Federico II”, two antibiotics were employed to tackle the issue of the infections and they are compared in this paper to find which one implies the lowest length of hospital stay (LOS) and the reduction of infections.Design/methodology/approachThe Six Sigma methodology and its problem-solving strategy DMAIC (define, measure, analyse, improve, control), already employed in the healthcare sector, were used as a tool of a health technology assessment between two drugs. In this paper the DMAIC roadmap is used to compare the Ceftriaxone (administered to a group of 48 patients) and the association of Cefazolin plus Clindamycin (administered to a group of 45 patients).FindingsThe results show that the LOS of patients treated with Ceftriaxone is lower than those who were treated with the association of Cefazolin plus Clindamycin, the difference is about 41%. Moreover, a lower number of complications and infections was found in patients who received Ceftriaxone. Finally, a greater number of antibiotic shifts was needed by patients treated with Cefazolin plus Clindamycin.Research limitations/implicationsWhile the paper enhances clearly the advantages for patients' outcomes regarding the LOS and the number of complications, it did not analyse the costs of the two antibiotics.Practical implicationsEmploying the Ceftriaxone would allow the Department of Maxillofacial Surgery to obtain lower LOS and a limited number of complications/infections for recovered patients, consequently reducing the hospitalization costs.Originality/valueThere is a double value in this paper: first of all, the comparison between the two antibiotics gives an answer to one of the main issues in medicine that is the reduction of hospital-acquired infections; secondly, the Six Sigma through its DMAIC cycle can be employed also to compare two biomedical technologies as a tool of health technology assessment studies.

Sign in / Sign up

Export Citation Format

Share Document